U.S. Faces Measles Elimination Ruling in November After 20-Month Resurgence
Updated
Updated · POLITICO · Oct 20
U.S. Faces Measles Elimination Ruling in November After 20-Month Resurgence
3 articles · Updated · POLITICO · Oct 20
Summary
Mid-November could decide whether the U.S. keeps its measles elimination status, as PAHO reviews CDC data to determine if any single transmission chain lasted more than 1 year.
An independent U.S. sustainability committee has already examined the CDC report and will present its view to PAHO, with chair Noel Brewer saying whole-genome sequencing offers a more precise way to separate linked outbreaks.
Utah is a key example: outbreaks there are believed to have stretched beyond a year, but public genomic data suggest they may include multiple distinct transmission chains rather than one uninterrupted spread.
The stakes are unusually high because the U.S. has logged more measles cases during this 18-month review period than in the previous quarter-century combined; losing the designation would be the first time since 2000.
Brewer said the surge is part of a broader North American hotspot—Canada already lost elimination status last year—while urging stronger school vaccine requirements, targeted outreach and clearer pro-vaccination messaging from top health officials.